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Neonicotinoids, a widely used group of pesticides designed to selectively bind to
insect nicotinic acetylcholine receptors, were considered relatively safe for mammalian
species. However, they have been found to activate vertebrate nicotinic acetylcholine
receptors and could be toxic to the mammalian brain. In the present study, we evaluated
the developmental neurotoxicity of acetamiprid (ACE), one of the most widely used
neonicotinoids, in C57BL/6J mice whose mothers were administered ACE via gavage
at doses of either 0 mg/kg (control group), 1.0 mg/kg (low-dose group), or 10.0
mg/kg (high-dose group) from gestational day 6 to lactation day 21. The results of a
battery of behavior tests for socio-sexual and anxiety-related behaviors, the numbers of
vasopressin-immunoreactive cells in the paraventricular nucleus of the hypothalamus,
and testosterone levels were used as endpoints. In addition, behavioral flexibility in mice
was assessed in a group-housed environment using the IntelliCage, a fully automated
mouse behavioral analysis system. In adult male mice exposed to ACE at both low
and high doses, a significant reduction of anxiety level was found in the light-dark
transition test. Males in the low-dose group also showed a significant increase in
sexual and aggressive behaviors. In contrast, neither the anxiety levels nor the sexual
behaviors of females were altered. No reductions in the testosterone level, the number
of vasopressin-immunoreactive cells, or behavioral flexibility were detected in either sex.
These results suggest the possibility that in utero and lactational ACE exposure interferes
with the development of the neural circuits required for executing socio-sexual and
anxiety-related behaviors in male mice specifically.
Keywords: neonicotinoids, acetamiprid, In utero and lactational exposure, sociosexual behavior, anxiety-related
behavior
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INTRODUCTION
There is a growing concern that exposure to environmental
chemicals in early life may interfere with brain development
(Júlvez et al., 2016). In particular, neonicotinoid pesticides have
drawn considerable attention. As a pesticide class, neonicotinoids
are designed to overstimulate insect nicotinic acetylcholine
receptors (nAChRs). These pesticides were previously thought
to be relatively harmless to mammalian species because of their
low binding affinities to mammalian nAChRs (Tomizawa and
Casida, 1999, 2005). However, recent in vivo and in vitro studies
have reported that neonicotinoids possess sufficient binding
affinity and agonistic potential for mammalian nAChRs to exert
nicotine-like effects that are stronger than originally believed
(de Oliveira et al., 2010; Rodrigues et al., 2010; Li et al., 2011;
Kimura-Kuroda et al., 2012). Neonicotinoids such as acetamiprid
(ACE), imidacloprid, and clothianidin can bind to the α4 and β2
subunits of mammalian nAChRs (Tomizawa and Casida, 1999;
Li et al., 2011; Kimura-Kuroda et al., 2012). The α4β2 nAChRs
are present in various brain regions such as the amygdala,
hypothalamus, substantia nigra, ventral tegmental area, raphe
nuclei, hippocampus, and medial habenula (Cimino et al., 1995;
Millar and Gotti, 2009), and regulate the development and
functions of these regions (Dwyer et al., 2009; Takarada et al.,
2012). These brain regions are involved in the regulation of socio-
sexual behaviors, anxiety, depression, memory, and learning
(Pfaff, 1989; Newman, 1999; Nelson and Trainor, 2007; Drevets
et al., 2008; Gaskin and White, 2013; Russo and Nestler, 2013).
Therefore, perinatal exposure to neonicotinoids is thought to
impair specific behaviors by affecting the formation of neuronal
circuits, including circuits involving these areas.
Since ACE has a higher affinity and potency for mammalian
nAChRs compared to those of other neonicotinoids (Tomizawa
and Casida, 1999; Kimura-Kuroda et al., 2012), we here studied
effects of perinatal exposure to ACE on murine behaviors
later in adulthood, focusing on socio-sexual and anxiety-related
behaviors and behavioral flexibility. In addition to examining
these adult behaviors, we evaluated the blood testosterone
levels and the numbers of cells expressing arginine-vasopressin
(AVP) in the hypothalamus because they are closely associated
with socio-sexual and anxiety-related behaviors (Hull and
Dominguez, 2007; Nelson and Trainor, 2007; Ho et al., 2010;
Stevenson and Caldwell, 2012).
MATERIALS AND METHODS
Animals
Male and female C57BL/6J mice were purchased from CLEA
Japan (Tokyo, Japan) and mated at the National Institute for
Environmental Studies (NIES). Mice were housed in a room
that was maintained at a constant temperature (24 ± 1◦C) and
humidity (50 ± 10%) with a 12/12-h light/dark cycle. Food
and water were provided ad libitum unless otherwise specified.
The presence of vaginal plugs was checked daily; gestational day
(GD) 0 was defined as the day on which a vaginal plug was
detected. The dams were administered ACE (Sigma-Aldrich, St.
Louis, MO), dissolved in H2O, at doses of 0 mg/kg (control
group), 1.0mg/kg (low-dose group), or 10.0 mg/kg (high-dose
group) by oral gavage from GD 6 to postnatal day (PND) 21.
The litters were weaned from their mothers 2–3 h after the
last ACE administration on PND 21 and housed with same-sex
littermates. All procedures were approved by the Animal Care
and Use Committee at the NIES and were conducted strictly in
accordance with the NIES guidelines.
Body Weights
The body weight (BW) was measured at birth, at weaning (PND
21), and at 23–26 weeks of age, and the average body weight
within a litter (BW/litter) was compared between treatment
groups.
Brain Weights
At the time of weaning (PND 21), randomly selected mice that
would not be used for behavioral testing were deeply anesthetized
with isoflurane and decapitated. The brains were rapidly removed
and weighed.
ACE Analysis in the Brain
An ACE standard was obtained from Sigma-Aldrich.
Acetamiprid-d3 (Fluka, Sigma-Aldrich, St. Louis, MO, USA)
was used as an internal standard (IS). The standard and IS were
diluted with acetonitrile and stored at −20◦C. Acetonitrile,
acetic acid (LC-MS grade), and ammonium acetate (JIS Special
Grade) were purchased from Wako Pure Chemical. Purified
water was prepared by MilliQ filtration (Millipore, Billerica, MA,
USA). The brain levels of ACE were analyzed using previously
reported analytical methods with some modifications (Seccia
et al., 2008; Xiao et al., 2011; Zhang et al., 2012; Ueyama et al.,
2014; Gbylik-Sikorska et al., 2015). A whole brain (0.34–0.49 g)
was transferred to a 15mL polypropylene (PP) tube and mixed
with 500 µL of purified water and 50 µL of 50 ng/mL IS solution.
The solution was homogenized using a Handy Ultrasonic
Homogenizer (Microtec, Funabashi, Chiba, Japan) for 2min.
After adding 2mL of acetonitrile, the sample solution was
vortexed and ultrasonically extracted for 5min. The extract
was centrifuged at 3500 rpm for 5min (Centrifugator, H-36,
Kokusan, Saitama, Japan,), transferred to another 15mL PP tube,
and the solvent was evaporated with a centrifugal evaporator
(CentriVap, Asahi Life Science, Saitama, Japan) for 90min. The
residue was re-dissolved in 0.1mL of acetonitrile and diluted
with purified water, up to 1mL. The sample solution was passed
through an Oasis HLB cartridge (1mL/30mg, Waters) that was
pre-conditioned with 1 mL of acetonitrile and 1mL of purified
water. After rinsing with 1mL of purified water, the ACE was
eluted with 1mL of acetonitrile/purified water (1:1, v/v). The
eluates were evaporated with a centrifugal evaporator for 60min
and re-dissolved in 0.5mL of acetonitrile/purified water (1:9,
v/v) prior to the analysis. Quantification was performed using
an ultra-high performance liquid chromatography (Nexera
UHPLC, Shimadzu, Kyoto, Japan) coupled to a tandem mass
spectrometry (LCMS8050, Shimadzu). The analytical column
was Kinetex C18 (100 × 2.1mm, 2.6 µm, Phenomenex,
Torrance, CA, USA), and the injection volume was 10 µL.
The mobile phase was (a) 17 mmol/L acetic acid and 5 mmol
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ammonium acetate in acetonitrile and (b) 17 mmol/L acetic acid
and 5 mmol ammonium acetate in purified water; the flow rate
was maintained at 0.4 mL/min. The gradient parameters were
as follows: the initial condition (phase ratio a:b = 10:90) for
5 min, 40:60 for 5.5min, 100:0 for 1min, the initial condition
for 6 min. A multiple reaction monitoring (MRM; precursor
ion: m/z = 222.7 and product ion: m/z = 126.0) transition was
used for the ACE quantification, and another MRM transition
(precursor ion: m/z = 222.7 and product ion: m/z = 56.2) was
used for confirmation. Quantification was performed using the
relative response to IS. The linearity of the calibration curve
of the ACE standard solution was confirmed from 0.1 to 100
ng/mL, with r2 > 0.998. The instrumental detection limit (IDL)
of ACE was 0.024 ng/mL, which was calculated from the results
of 7 replicate analyses of the standard solution. To calculate the
method detection limit (MDL), 7 replicated analyses of a fortified
blank sample were performed. The blank sample (0.4 mL of
purified water) was spiked with 0.05mL of 0.1 ng/mL standard
solution and processed throughout the analytical procedure. The
MDL was calculated to be 0.032 ng/g. The IS recovery during the
sample analysis ranged from 63 to 98%. The extraction efficiency
was evaluated by repeated extraction; the detected ACE level
were below the IDL in the second and third extractions.
General Test Procedure
When the offspring were 9–12 weeks old, 1 or 2 mice of both
sexes were randomly selected from each litter for a behavioral
test battery for socio-sexual and anxiety-related behaviors,
consisting of tests for male and female sexual behaviors,
aggressive behaviors, and the light-dark transition (LDT) test.
The behavioral tests were performed during the dark phase
(starting more than 2 h after lights off) of the light/dark cycle
under red light. After completing the behavioral tests, the mice
were sacrificed, and blood and brain samples were collected for
the enzyme immunoassays and immunohistochemistry.
Another 1–2 mice of both sexes from each litter (males: 13–
20 weeks of age; females: 23–32 weeks of age) were assigned
to the behavioral flexibility test using the IntelliCage apparatus
(NewBehavior AG, Zurich, Switzerland). The experimental
design for the tests and the number of animals for each group
are shown in Figure 1.
Male Sexual Behavior
The male mice were separated from their littermates and
individually housed in plastic cages (5 × 22 × 12 cm). Starting
12–14 days later, each mouse was tested in its home cage for
sexual behavior toward ovariectomized and sex-hormone-treated
C57BL/6J female mice once weekly for 3 weeks. The duration of
each trial was 30min. All female stimulus mice were primed with
subcutaneous injections of estradiol benzoate (EB) in sesame
oil (10 µg/0.1mL) twice before testing (at 24 and 48 h). The
mice were also administered progesterone (P) in sesame oil (500
µg/0.1mL) 4−6 h before testing to ensure high sexual receptivity.
All tests were video-recorded; the numbers of attempted mounts,
successful mounts, intromissions, and ejaculations were scored
for each mouse.
Male Aggressive Behavior
Five to Seven days after the last sexual behavior test, each male
mouse was tested for its aggressive behavior against a gonadally
intact, olfactory-bulbectomized C57BL/6J male intruder mouse
using a resident-intruder paradigm. This test was performed
weekly for 3 consecutive days, for a total of 9 trials. The duration
of each trial was 15 min. All tests were video-recorded; the
duration and number of aggressive bouts toward the intruder
were scored for each mouse. The data for the 3 trials obtained
each week were averaged for each mouse and used for statistical
analysis. An aggressive bout was defined as a set of behavioral
interactions that included at least one of the following behavioral
actions toward the intruder: chasing, boxing, wrestling, biting,
tail rattling, and offensive lateral attack. If the interval between
2 aggressive bouts did not exceed 3 s, the 2 bouts were considered
to be continuous and scored as 1 bout.
Female Sexual Behavior
At 10–12 weeks of age, the female mice were separated from their
littermates and housed individually in plastic cages (5 × 22 ×
12 cm). Fourteen to Sixteen days after the isolation, all mice were
ovariectomized under isoflurane inhalation anesthesia. Fourteen
to Sixteen days after the ovariectomy, each female mouse was
tested for sexual behavior toward a sexually experienced ICR/JCL
male mouse (CLEA Japan, Tokyo, Japan) in the male’s home
cage. This test was performed weekly, for a total of 3 trials.
The female mice were subcutaneously injected with EB (5
µg/0.1mL dissolved in sesame oil) at 24 and 48 h before testing,
and P (250µg/0.1mL dissolved in sesame oil) at 4–6 h before
testing. Each test lasted until females received 15 mounts or
intromissions. The number of lordosis responses to the male
mounts or intromissions was scored for each mouse. A lordosis
quotient was calculated by dividing the number of lordosis
responses by 15 mounts or intromissions (Ogawa et al., 1999).
The LDT Test
Each mouse was tested once for its emotional behaviors in
the LDT apparatus for 10min. The test apparatus consisted
of enclosed dark and open-top light compartments (30 × 30
× 30 cm each) connected by an inner door way (3 × 3 cm)
located in the center of the partition at the floor level. The open-
top light compartment was brightly illuminated with a white
light (350 lux). The latency to enter the light compartment, the
cumulative time spent in the light compartment, and the total
distance traveled in the light compartment were measured by an
automated video tracking system (ANY-maze, Stoelting, USA).
The data from 2 male mice (1 in the control group and 1 in
the low-dose group) were excluded from the analysis because of
recording errors.
Sample Collection
After completing the behavioral tests, mice were deeply
anesthetized with sodium pentobarbital (60 mg/kg), and blood
was collected from the left ventricle of each mouse. The mice
were subjected to transcardial perfusion with 0.1 M phosphate-
buffered saline (PBS; pH 7.2), followed by 4% paraformaldehyde
(PFA) in 0.1 M PBS. Brains were removed, post-fixed overnight
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FIGURE 1 | Timeline of the behavioral tests in the study and information of the numbers of animals used in each cohort.
FIGURE 2 | Effects of developmental ACE exposure on male sexual behavior. Comparison of (A) the total number of sexual behaviors, as well as the numbers
for each male sexual behavior component, including (B) attempted mounts, (C) mounts, and (D) intromissions across the treatment groups. The numbers of animals
used are indicated in parentheses. The data are presented as the mean ± SEM. *P < 0.05, aP < 0.1.
at 4◦Cwith 4% PFA in 0.1M PBS, and cryoprotected in 0.1M PBS
containing 30% sucrose.
Enzyme Immunoassay for Plasma
Testosterone
Samples were extracted from plasma (100 µl) with ethyl
acetate, and testosterone concentrations were determined using a
testosterone enzyme immunoassay kit (Cayman Chemicals, Ann
Arbor, MI, USA), according to the manufacturer’s instructions.
All male samples and randomly selected samples from females
(5 for each treatment group) subjected to the socio-sexual and
anxiety behavior tests were analyzed.
Immunohistochemistry
The brain samples were coronally sectioned at 30 µm thickness
with 90 µm intervals on a freezing microtome. Sections were
incubated in PBS-X (0.1 M PBS, pH 7.2 and 0.2% Triton
X-100), containing 0.5% hydrogen peroxide for 20 min to
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FIGURE 3 | Effects of developmental ACE exposure on male aggressive behavior. (A) The total duration and (B) the number of aggressive bouts toward the
intruder stimuli. The numbers of animals used are indicated in parentheses. The data are presented as the mean ± SEM. **P < 0.01, *P < 0.05.
inhibit the endogenous peroxidase activity, and then blocked
in an incubation buffer (1% casein in PBS-X) for 2 h at room
temperature. Tissue sections were then incubated with a rabbit
polyclonal anti-vasopressin antiserum (1:4000; Immunostar Cat.
#20069, Hudson, NY, USA) in incubation buffer for 24 h
at 4◦C. After the completion of the incubation process, the
staining was visualized using the DAKO EnVisionTM Detection
System (Peroxidase/DAB+, K5007). Three anatomicallymatched
sections (30 µm thickness, 90 µm intervals) containing the
paraventricular nucleus (PVN, bregma 0.70–0.94 mm) were
selected for each mouse. PVN images were photographed at a
10x magnification with a digital camera mounted on a light
microscope (Leica DFC290 HD; Leica Microsystems, Wetzlar,
Hesse, Germany). The total number of immunoreactive cells
was bilaterally counted for each animal. Because of technical
issues with the sample preservation and tissue preparation, only
the number of samples denoted in Figure 7 were used for the
analysis.
Evaluation of Behavioral Flexibility Using
the IntelliCage
Male and female mice were tested separately for their behavioral
flexibility using the IntelliCage, a fully automated testing
apparatus consisting of a large plastic cage (55 × 37.5 ×
20.5 cm) equipped with 4 corner chambers (15 × 15 × 21 cm
each). Male mice at the age of 13–20 weeks were introduced
to the IntelliCage apparatus and housed for 57 days. The
female mice were housed in the apparatus for 56 days, starting
at the age of 23–32 weeks. The difference in test timing of
test was due to the limited capacity of the IntelliCage. Two
to Three days before being introduced to the apparatus, the
mice were anesthetized with isoflurane and subcutaneously
implanted a glass-covered transponder having a unique ID code
for radiofrequency identification (Datamars, Temple, TX, USA).
The behavioral flexibility test paradigm was composed of
an acquisition phase and serial reversal phases. Prior to the
behavioral flexibility test, the mice were allowed to acclimatize
to the IntelliCage for 9 days. In the acquisition phase after
acclimatization, mice were allowed to learn the two rewarded
corners and shuttle between them. Subsequently, the mice were
subjected to serial reversal tasks, in which the diagonal spatial
patterns of the rewarded corners was repetitively reversed every
FIGURE 4 | Effects of developmental ACE exposure on female sexual
behavior. The comparison of the lordosis quotient [(the number of lordosis
responses/15 mounts or intromissions) * 100]. The numbers of animals used
are indicated in parentheses. The data are presented as the mean ± SEM.
4–7 sessions. In total, there were 57 sessions for the male
mice and 56 sessions for the female mice, including the first
14 sessions of the acquisition phase. Additional sessions were
conducted with 10 serial reversals for the male mice and 9 serial
reversals for the female mice. The percentage of visits to the non-
rewarded corners within the first 100 visits was defined as the
discrimination error rate and used to analyze the inter-session
comparisons of learning performance. Additionally, the nose-
poke frequency per visit within the first 100 visits was calculated
for eachmouse as an index of compulsive repetitive behavior. The
IntelliCage apparatus and behavioral flexibility test paradigm are
described in details elsewhere (Endo et al., 2011, 2012). The data
from session 38–41 (6th reversal phase) and session 46–53 (8th
and 9th reversal phases) in the male mice were excluded from
analysis because of a mechanical malfunction of the IntelliCage
apparatus. Thus, in the Figure 8A, the sessions 42–45, which
were the 7th reversal phase, are denoted as Rev 6 and sessions
54–57, which were the 10th reversal phase, are denoted as Rev 7.
Statistical Analyses
All data are presented as mean ± standard error of the mean
(SEM). All data, except the comparison of the numbers of
ejaculating males, were analyzed using an ANOVA, followed
by a Fisher’s PLSD post hoc test. The incidence of ejaculation
during themale sexual behavior test was compared usingχ2 tests.
The differences were considered statistically significant when P
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FIGURE 5 | Effects of developmental ACE exposure on anxiety-related behaviors, as measured in the light-dark transition test. (A–C) Male and (D–F)
female mice of each treatment group. The comparison of (A,D) the total time spent in, (B,E) the total moving distance in, and (C,F) the latency to enter the light
compartment of the light-dark transition apparatus. The numbers of animals used are indicated in parentheses. The data are presented as the mean ± SEM. *P <
0.05 vs. control.
FIGURE 6 | Effects of developmental ACE exposure on plasma
testosterone levels. (A) Male and (B) female mice of each treatment group.
The numbers of animals used are indicated in parentheses. The data are
presented as the mean ± SEM.
< 0.05. All data were analyzed using the SPSS 19.0 statistical
package (SPSS Inc., Chicago, IL, USA) or R software (The R
Foundation for Statistical Computing, Vienna, Austria).
RESULTS
Body Weight/Litter
In the male and female mice, no differences were found in
BW/litter among the groups at birth, PND 21, or 23–26 weeks
of age (Table 1).
Brain Weight
No differences were found in the brain weights of either male or
female mice at PND 21 (Table 2). There were no differences in
the brain-to-body weight ratio either [data not shown].
Brain Residual Concentration Analysis
The brain residual concentration of ACE was measured in 6 mice
(3 male and 3 female) from the control group and 6 mice (3 male
and 3 female) from the high-dose group. The concentrations
in the high-dose group were 1.29 ± 0.46 and 1.23 ± 0.20 ng/g
in males and females, respectively (Table 3). In contrast, the
concentrations were below theMDL in the control group for both
sexes.
Male Sexual Behavior
In the male sexual behavior test (Figures 2A–D), the total
number of sexual behaviors was significantly increased in the
low-dose group [F(2, 27) = 3.72, P< 0.05; Fisher’s PLSD, P< 0.05,
low-dose group vs. control and high-dose groups; Figure 2A],
particularly for the mean number of mounts [F(2, 27) = 3.77, P <
0.05; Fisher’s PLSD, P < 0.05, low-dose group vs. control group;
Figure 2C]. We found no significant difference in the incidence
of ejaculation during the tests (Table 4).
Male Aggressive Behavior
The aggression level in the low-dose group was significantly
increased compared to that of the control and high-dose groups,
as measured by the total duration [F(2, 27) = 4.44, P < 0.05;
Fisher’s PLSD, P < 0.05, low-dose group vs. control; P <
0.01, low-dose group vs. high-dose group; Figure 3A] and the
number of bouts [F(2, 27) = 6.24, P < 0.01; Fisher’s PLSD,
P < 0.01, low-dose group vs. control and high-dose groups;
Figure 3B].
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FIGURE 7 | Effects of developmental ACE exposure on the number of
vasopressin (AVP) immunoreactive (ir) cells in the paraventricular
nucleus (PVN). (A) Male and (B) female mice of each treatment group. The
data are presented as the mean ± SEM. (C) Representative
photomicrographs of AVP-ir cells in brain sections from males (top panels) and
females (bottom panels) of each treatment group. The numbers of animals
used are indicated in parentheses (A,B). The scale bar represents 200 µm.
Female Sexual Behavior
No significant differences were found in the lordosis quotient
among the groups, whereas the lordosis quotient increased with
repeated testing in all groups [F(2, 48) = 12.83, P < 0.001;
Figure 4].
The LDT Test
The male mice in both the low-dose and high-dose groups spent
significantlymore time in the light compartment compared to the
control group [F(2, 25) = 3.83, P < 0.05; Fisher’s PLSD, P < 0.05,
low-dose and high-dose groups vs. control group; Figure 5A].
The male mice in the low-dose and high-dose groups tended to
travel longer distances in the light compartment compared to
the control group [F(2, 25) = 3.27, P = 0.055; Figure 5B]. We
found no significant differences in the latency to enter the light
compartment (Figure 5C). In contrast to the males, there were
no significant group differences in the females in the time spent
in the light compartment (Figure 5D), the total distance traveled
in the light compartment (Figure 5E) and the latency to enter the
light compartment (Figure 5F).
Plasma Testosterone Levels
The plasma testosterone levels were significantly higher in the
males compared to those of the females, regardless of treatment
[F(1, 39) = 7.48, P < 0.01; Figures 6A,B]. No main effect of ACE
exposure was found on the plasma testosterone levels in either
the males (Figure 6A) or females (Figure 6B).
AVP Immunoreactivity in the PVN
No main effect of ACE exposure was found on the number
of AVP immunoreactive cells in either the males (Figure 7A)
or females (Figure 7B). The number of AVP-immunoreactive
cells was significantly higher in the males than in the females,
regardless of treatment [F(1, 20) = 26.7, P < 0.01; Figures 7A,B]
as shown in representative photomicrographs (Figure 7C).
Behavioral Flexibility Test
During the acclimatization period, the number of corner visits
per week in the IntelliCage did not differ between the groups
in both males and females (Supplementary Figure 1), indicating
the possibility that the developmental exposure to ACE does
not affect home cage activity. In the acquisition phase, the
male and female mice in all groups showed a decrease in the
discrimination error rate with repeated sessions. No statistical
differences were found between the groups, indicating that all
groups could acquire the first task (Figures 8A,B). In the serial
reversal phase, the male and female mice in all groups showed
a similar pattern in the discrimination error rate in the reversal
stage (Rev), indicating that the developmental ACE exposure had
no effect on the spatial learning ability and behavioral flexibility
during adulthood. We measured the nose-poke/visit ratio, which
is an index of behavioral impulsivity, against rewards in the home
cage, but found no significant group differences.
DISCUSSION
We evaluated the general physiological parameters, such as
body and brain weights, during the developmental period of
mice exposed to ACE in utero and via lactation, as well as
a battery of socio-sexual and anxiety-related behaviors during
their adulthood. ACE was found in the brains of pups of the
high-dose group at PND 21, using a residual concentration
analysis. These data showed that absorbed ACE was transferred
into the developing brain. The ACE exposure at the used doses
did not alter the body and brain weights. In addition, no
impairments in behavioral flexibility were found in the in utero
and lactational ACE-exposed adult mice. On the other hand,
in utero and lactational ACE exposure altered socio-sexual and
anxiety-related behaviors in males.
Although, the binding affinity of ACE to nAChRs is
approximately 70–80 times lower than that of nicotine
(Tomizawa and Casida, 1999; Picciotto et al., 2001), ACE
can be bound to nAChRs containing α4 and β2 subunits, which
are known to mediate the effects of nicotine. Based on this
binding affinity difference, we propose that the effect of ACE
on certain behaviors may correspond to the effect of nicotine at
lower doses. Therefore, in our discussion below, we attempt to
compare the present results to previous reports demonstrating
the effects of developmental nicotine exposure at relatively low
doses, when possible.
We found significant changes in the socio-sexual and anxiety-
related behaviors in male mice exposed to ACE in utero and
via lactation. The most significant change was found by the
LDT test. ACE exposure at low or high doses prolonged the
time spent in the light compartment, indicating reduction of
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FIGURE 8 | Effects of developmental ACE exposure on behavioral flexibility. The comparison of the discrimination error rates (the number of discrimination
errors in the first 100 corner visits in the session) in (A) male and (B) female mice. The numbers of animals used are indicated in parentheses. The data are presented
as the mean ± SEM. The data for session 38–41 (6th reversal phase) and session 46–53 (8th and 9th reversal phases) in male were omitted due to the technical
issues with the IntelliCage apparatus. Thus, the session 42 to 45 is denoted as Rev 6 and the session 54–57 is denoted as Rev 7 on (A).
anxiety. This result suggests that there may be altered emotional
responses in the ACE-exposed male mice. There have been many
reports regarding the effects of nicotine exposure on anxiety-
related behaviors during the developmental period. However,
the effects of perinatal nicotine exposure reported in these
studies are bidirectional, positive or negative, depending on the
experimental conditions such as the dose, time of administration,
and the behavioral test paradigm.Maternal nicotine exposure at a
dose of 0.5 mg/kg BW from GD 10 to delivery in mice is reported
to decrease anxiety-related parameters measured in the elevated
plus-maze test in male offspring (Ajarem and Ahmad, 1998). In
contrast, male mice whose mothers were exposed to nicotine
(0.2 mg/ml) in drinking water throughout gestation or from GD
14 to delivery have been reported to exhibit increased anxiety-
related responses in both the elevated plus-maze and LDT tests
(Alkam et al., 2013). Vaglenova et al. (2004) reported that nicotine
exposure in pregnant rats at a daily dose of 6.0 mg/kg BW
from GD 3 to delivery also causes increased anxiety-related
responses in their offspring as assessed in the elevated plus-maze
test. The relationship between developmental nicotine exposure
and anxiety shown by many studies allows us to speculate
that the neural circuitry responsible for anxiety is vulnerable to
cholinergic agents, although reservation is warranted because of
inconsistencies among previous studies. In addition, perinatal
nicotine exposure is reported to cause hyperactivity in rodents
(Ajarem and Ahmad, 1998; Thomas et al., 2000; Pauly et al.,
2004; Vaglenova et al., 2004; Paz et al., 2007; Heath et al., 2010;
Alkam et al., 2013). We did not find any differences between
the groups in corner visits in the IntelliCage, demonstrating no
differences in home cage activity between the groups. However,
mice exposed to ACE at both the low and high doses tended to
travel longer distances in the light compartment, suggesting the
possibility that ACE exposure may have induced hyperactivity
under specific stressful conditions. Therefore, the longer times
spent in the light compartment in the LDT test may reflect
not only decreased anxiety, but also hyperactivity under specific
stressful conditions. Future experiments measuring locomotor
activity with or without stress are necessary to clarify whether
ACE exposure decreases low anxiety, induces hyperactivity, or
both under stressful conditions.
On socio-sexual behaviors, the effect of ACE appeared to
be dose-specific. ACE exposure at the low dose, but not at the
high dose, significantly increased male sexual and aggressive
behaviors. Socio-sexual behaviors are governed by neural circuits
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TABLE 1 | Body weight per litter (BW/litter) at birth, weaning (PND21), and
23–26 weeks of age.
Groups Birth (g) PND21 (g) 23–26 weeks (g)
Male Control 1.27 ± 0.02 (7) 7.85 ± 0.12 (6) 28.28 ± 0.57 (5)
Low 1.30 ± 0.02 (6) 8.01 ± 0.37 (6) 30.09 ± 0.68 (5)
High 1.31 ± 0.04 (9) 7.72 ± 0.39 (9) 28.08 ± 0.66 (6)
Female Control 1.22 ± 0.02 (7) 7.38 ± 0.14 (6) 25.63 ± 0.72 (4)
Low 1.29 ± 0.03 (6) 7.76 ± 0.27 (5) 25.82 ± 0.50 (5)
High 1.31 ± 0.03 (9) 7.43 ± 0.31 (9) 24.85 ± 0.33 (5)
Data presented as mean ± SEM.
Number of dam is given in parentheses.
TABLE 2 | Brain weight at PND 21.
Groups Brain weight (g)
Male Control (n = 6) 0.41 ± 0.007
Low (n = 2) 0.44
High (n = 4) 0.41 ± 0.008
Female Control (n = 6) 0.40 ± 0.003
Low (n = 4) 0.41 ± 0.003
High (n = 6) 0.39 ± 0.013
Data presented as mean ± SEM.
TABLE 3 | Residual concentration of ACE in the brains of offspring
at PND 21.
Groups Brain residual concentration
(ng/mg tissue)
Male Control (n = 3) <MDL
High dose group (n = 3) 1.29 ± 0.46
Female Control (n = 3) <MDL
High dose group (n = 3) 1.23 ± 0.20
MDL: The method detection limit.
Data presented as mean ± SEM.
TABLE 4 | Number of male mice demonstrated ejaculation in each test.
Groups Test 1 Test 2 Test 3
Control 2/10 (20%) 2/10 (20%) 2/10 (20%)
Low 3/9 (33.3%) 2/9 (22.2%) 5/9 (55.6%)
High 2/11 (18.2%) 2/11 (18.2%) 4/11 (36.4%)
Number of mice ejaculated/total number of mice tested; the percentage is given in
parentheses.
involving various brain regions (Newman, 1999). Peripheral sex
steroid hormones play an essential role in the formation of these
neural circuits during the critical period. Generally in mammals,
the critical period can extend from late gestational period to
the early life (Hull and Dominguez, 2007; Nelson and Trainor,
2007). The cholinergic system is also thought to play a role in the
formation of the neural bases of these behaviors (Dwyer et al.,
2009; Blood-Siegfried and Rende, 2010). Any agents that block
or enhance acetylcholine transmission may interfere with this
formation.
The idea that low-dose chemical exposure alters specific
behaviors has been proposed in previous studies. Dioxin
and bisphenol A induce their toxicities in a non-monotonic
manner (Endo et al., 2012; Vandenberg, 2014). The actions
of nicotine also appear to be complex and non-monotonic,
especially when given in vivo (Anderson and Brunzell, 2012,
2015; Alkam et al., 2013; Abreu-Villaça et al., 2015). Behaviors
as well as specific neural circuit formation may potentially
be dysregulated by nicotine in a non-monotonic manner. For
example, the effect of developmental nicotine exposure on
the development of the vasopressinergic system is complex.
Prenatal nicotine exposure at a relatively high dose (6 mg/kg/day
throughout the gestational period) greatly reduced vasopressin
production and release in the hypothalamus of male rats
(Zbuzek and Zbuzek, 1992). Although, the species difference
must be taken into consideration, prenatal nicotine exposure at
a relatively low dose (total amount of 1.05mg throughout the
gestational period) has been reported to increase the number
of vasopressin cell bodies and fibers in the hypothalamus of
the golden hamster (Rossi et al., 2003). Since vasopressinergic
systems regulate both sexual and aggressive behaviors in a
facilitative manner (Ho et al., 2010; Stevenson and Caldwell,
2012), we speculated that ACE exposure specifically at the low
dose enhanced the development of neural networks involved
in vasopressinergic systems. However, we did not find any
differences in the number of AVP-immunoreactive cells in the
PVN. Therefore, it is unlikely that in utero and lactational
ACE exposure at the low dose increased aggression and
sexuality in adulthood through alterations of the vasopressinergic
system in the PVN. We could not examine the numbers of
AVP-immunoreactive cells in areas outside the PVN, such
as the bed nucleus of the stria terminalis (BNST), a region
known to be critically involved in the facilitation of male
socio-sexual behaviors (Newman, 1999; Nelson and Trainor,
2007). Further studies are needed to clarify whether ACE
affects AVP immunoreactive cells in brain regions other than
the PVN.
There have been several reports regarding the effects of in
utero nicotine exposure on plasma testosterone levels in animal
models, but these reports are also inconsistent with each other,
presumably due to differing exposure conditions. On one hand,
the plasma testosterone levels decreased in 10-week-old male rat
offspring born to dams that had been administered nicotine at
a dose of 0.5mg/kg throughout gestation (Segarra and Strand,
1989). In contrast, the plasma testosterone levels increased in 13-
week-old male rat offspring born to dams that had been given
nicotine at a dose of 2 mg/kg throughout gestation increased
(Paccola et al., 2014). In our study, we did not find any differences
in plasma testosterone levels measured at 23–26 weeks of age,
which excludes the possibility that increased testosterone levels
in adult males caused the abnormalities in the socio-sexual and
emotional behaviors. However, we did not determine plasma
testosterone levels during the perinatal period, which is a critical
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period for the testosterone-induced masculinization of socio-
sexual behaviors. Therefore, we cannot exclude the possibility
that developmental ACE exposure altered the testosterone levels
during the perinatal periods, resulting in the impaired sexual
differentiation of socio-sexual behaviors.
Behavioral flexibility was unaffected by developmental ACE
exposure under our exposure conditions. Behavioral flexibility
is considered a part of executive function, which is dependent
on hippocampal and prefrontal cortical function (Kosaki and
Watanabe, 2012; Malá et al., 2015). Various studies have reported
the negative effects of developmental nicotine exposure at
relatively high doses on the cognitive performance of offspring
(Yanai et al., 1992; Wickström, 2007; Parameshwaran et al.,
2012). However, the effects of developmental nicotine exposure
to neonicotinoids or lower doses of nicotine have not been
clarified for cognitive functions. Our study demonstrated that
the developmental ACE exposure did not affect the cognitive
functions, at least at the ACE doses and animal ages tested in this
study. However, we cannot exclude the possibility that late-onset
impairment of cognitive function occurs inmice exposed to ACE.
Since malfunction of the cholinergic system is associated with
cognitive deficits such as those in Alzheimer’s disease (Schliebs
and Arendt, 2011), examining behavioral flexibility in aged mice
exposed to ACE perinatally would be an interesting avenue of our
research.
Sex differences in the effects of ACE exposure on socio-sexual
and emotional behaviors should also be addressed since in utero
and lactational ACE exposure at either dose had no effect on
female sexual behavior and anxiety. The present study was unable
to elucidate the neuropathologies underlying the sex-specific
effect of ACE. Several lines of evidence suggest that the male is
more susceptible to developmental nicotine exposure than the
female (Fung and Lau, 1989; Ribary and Lichtensteiger, 1989; von
Ziegler et al., 1991; Pauly et al., 2004). The sex-specific effect of
ACE observed in this study is consistent with the reported male–
biased effects of nicotine, possibly suggesting that nicotine and
ACE elicit toxic effects through a common sex-specific pathway.
It is also important to mention that ACE was administered to
mice throughout the gestational and lactational periods in this
study. The effect of developmental nicotine exposure has been
reported to vary depending on the timing of exposure (Alkam
et al., 2013). Therefore, if ACE shares a common toxic pathway
with nicotine, it is highly likely that the effect of ACE also varies
depending on the timing of exposure. The developmental action
of ACE in different time-windows should be further examined in
future studies.
CONCLUSION
Our results suggest the possibility that ACE affects socio-sexual
and anxiety-related behaviors in a male-specific manner. Further
experiments are needed to understand the behavioral alterations
and examine the mechanisms underlying the ACE-induced
impairments in brain function. The action of ACE appears to
be non-monotonic for the socio-sexual behaviors, as the effects
were only found in mice exposed to ACE at low doses. Further
empirical studies using mouse models are required to evaluate
whether ACE doses equivalent to the human exposure level have
detrimental effects.
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